A Phase II, Randomized, Multicenter Study Evaluating the Combination of Lapatinib and Vinorelbine in Women With ErbB2 Overexpressing Metastatic Breast Cancer
Breast Cancer Research and Treatment - Netherlands
doi 10.1007/s10549-013-2828-z
Full Text
Open PDFAbstract
Available in full text
Date
January 9, 2014
Authors
Publisher
Springer Science and Business Media LLC